Related Experiment Videos
Current therapy of major fungal diseases of the lung
1Division of General Internal Medicine, University of Texas Medical School, Houston.
Abstract:
The treatment of the major systemic fungi encountered in the United States--Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis--depends on an understanding of the natural history of disease. Clinical manifestations of these infections can range from an asymptomatic disease that requires no therapy to an illness that is incurable and requires long-term suppression with antifungal agents to produce a balanced host-to-parasite relationship. This article discusses the natural history of disease caused by H. capsulatum, B. dermatitides, and C. immitis and various clinical situations that require antifungal chemotherapy.
Insights
Understanding the natural history of Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis infections is key for effective treatment. Antifungal chemotherapy is crucial for managing severe or chronic systemic fungal diseases.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Systemic fungal infections caused by Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis are significant health concerns in the United States.
- The clinical spectrum of these infections ranges from asymptomatic to life-threatening, necessitating tailored treatment approaches.
- Effective management hinges on a thorough understanding of the natural progression of each disease.
Purpose of the Study:
- To elucidate the natural history of diseases caused by H. capsulatum, B. dermatitides, and C. immitis.
- To outline clinical scenarios where antifungal chemotherapy is indicated.
- To provide a foundation for informed therapeutic decision-making in systemic fungal infections.
Main Methods:
- Review of the epidemiology and pathogenesis of Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis.
- Analysis of clinical manifestations and disease progression for each fungal pathogen.
- Correlation of disease severity with the need for antifungal treatment strategies.
Main Results:
- The natural history of H. capsulatum, B. dermatitides, and C. immitis infections varies widely, influencing treatment requirements.
- Asymptomatic infections often require no intervention, while severe or disseminated disease demands prompt antifungal therapy.
- Long-term suppression may be necessary for incurable conditions to maintain a host-parasite balance.
Conclusions:
- A comprehensive understanding of the natural history of these endemic mycoses is paramount for appropriate patient management.
- Antifungal chemotherapy plays a critical role in treating various clinical presentations of systemic fungal infections.
- Tailoring treatment based on disease natural history ensures optimal outcomes and management of chronic fungal diseases.